BDBM619246 US20230295119, Compound 18V::US20230295119, Compound 18X

SMILES CCC(=O)c1cnc(Nc2ccc(O[C@@H]3CCN(C)C3)cn2)cc1Nc1cccc(-c2ncn(C)n2)c1OC

InChI Key InChIKey=DNQSCGUBVGBKHV-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 619246   

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 275nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 275nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 500nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 500nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 500nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619246(US20230295119, Compound 18X | US20230295119, Compo...)
Affinity DataIC50: 500nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent